Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26.37	361.94	286.42
Graham Fair Price	11.75	38.79	34.71
PEG	17.41	6.54	5.57
Price/Book	2.39	19.44	18.99
Price/Cash Flow	23.42	132.99	107.76
Prices/Earnings	-7.49	113.54	122.74
Price/Sales	1.88	60.55	59.43
Price/FCF	23.42	132.99	107.76
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.52	0.80	0.79
Operating Margin	15.12	0.13	0.11
ROA	16.57	0.02	0.02
ROE	0.04	0.04	10.68
ROIC	0.02	0.03	20.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-54.65
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.17	0.23	36.01
EPS QOQ	0.22	0.17	-21.21
FCF QOQ	6.68	-0.12	-98.23
Revenue QOQ	0.07	0.07	4.60
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	80.41	0.00	inf
Days Sales Outstanding (DSO)	75.19	45.16	-39.95
Inventory Turnover	1.12	0.00	inf
Debt/Capitalization	0.23	0.16	-29.22
Quick Ratio	0.94	0.91	-2.69
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.21	39.53	6.22
Cash	23.79	24.95	4.89
Capex	-1.27	-0.76	40.26
Free Cash Flow	6.56	5.78	-11.88
Revenue	11.89	12.69	6.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.06	0.98	-7.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.76	0.48	-37.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating